Improving Decision-Making Encounters in Lung Cancer (I DECide) II: A Randomized Control Trial Of A Low-Literacy Conversation Tool

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:

• AIM 1: Suspected lung cancer

• AIM 1: English fluency

• AIM 1: \> 6-month life expectancy

• AIM 1: Score of ≥ 3 on the cognitive impairment screener

• AIM 2 PARTICIPANTS: Participation in Aim 1

• AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants

Locations
United States
Oregon
Hillsboro Medical Center
RECRUITING
Hillsboro
Adventist Health Portland
RECRUITING
Portland
OHSU Knight Cancer Institute
RECRUITING
Portland
Portland VA Medical Center
RECRUITING
Portland
Time Frame
Start Date: 2022-10-31
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 300
Treatments
Experimental: Group I (decision aid)
Patients review decision aid.
Active_comparator: Group II (standard of care)
Patients receive standard of care.
Related Therapeutic Areas
Sponsors
Leads: OHSU Knight Cancer Institute
Collaborators: Oregon Health and Science University, American Cancer Society, Inc.

This content was sourced from clinicaltrials.gov